Benjamin Michael Griffiths, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 108 North 1600 West, Mapleton Family Dentistry, Mapleton, UT 84664 Phone: 801-491-6844 Fax: 801-491-6044 |
Dr. Tanya Preston Westmoreland, D.D.S. Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 425 N Main St, Mapleton, UT 84664 Phone: 801-491-8191 Fax: 801-491-4912 |
Dallin Palmer, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 425 N Main St, Mapleton, UT 84664 Phone: 801-491-8191 Fax: 801-491-8191 |
Dr. Nathan Heywood, DDS Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 774 S 1600 W, Suite 103, Mapleton, UT 84664 Phone: 801-396-2944 |
News Archive
Learning if a lung cancer patient has genetic mutations can help oncologists determine the best approach to treatment. There are four gene mutations (KRAS, TP53, STK11, and EGFR) that most commonly occur in lung cancer; however, there are limited effective therapies to target these mutations. With this in mind, Moffitt Cancer Center performed an extensive genetic analysis of lung cancer specimens to unravel how mutations in the two of those genes (TP53 and STK11) contribute to the biology of lung cancer and patient outcomes.
Meru Networks, Inc., the leader in virtualized 802.11n enterprise wireless networking, today announced that Sarasota Memorial Health Care System, the second-largest acute care public medical center in Florida, selected Meru for pervasive wireless coverage throughout their 806-bed facility.
The consent forms that people sign before participating in research are widely considered difficult to understand and sometimes inaccurate. The lack of clarity was implicated in a high-profile legal settlement in April between Arizona State University and a Native American tribe, which claimed that blood samples that its members provided for genetic research were used for purposes not stated in the consent form. Efforts have been made to improve the forms, but how effective are they?
The Salk Institute has announced that it has signed a strategic alliance agreement with sanofi-aventis, establishing a joint program that supports cutting-edge research and promotes an exchange of discoveries focused on scientific advances and therapeutic applications.
China Shenghuo Pharmaceutical Holdings, a China-based pharmaceutical company engaged in the research, development, manufacture, and marketing of Traditional Chinese Medicine, nutritional supplement and cosmetic products, today announced that "Lixuwang", the trademark of its best selling product, Xuesaitong Capsule, was awarded the Chinese Well-Known Trademark Honor by the State Administration for Industry and Commerce of China.
› Verified 8 days ago